Literature DB >> 8084015

The activity of the protease of human immunodeficiency virus type 1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efficiency.

A H Kaplan1, M Manchester, R Swanstrom.   

Abstract

The final steps in the production of the type C retroviruses include assembly of the viral core particle and release of virions from the surface of the infected cell. The core proteins are translated as part of one of two precursors, Gag and Gag/Pol, which are cleaved by a virally encoded protease. We examined the interaction between the processing of the human immunodeficiency virus type 1 Gag precursor and the membrane-based assembly and budding of virions. Our results indicate that cleavage by the viral protease is initiated at the membrane of the infected cell during virus release and that protease activity is required for virion release to occur with maximum efficiency.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8084015      PMCID: PMC237104     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Generation of avian myeloblastosis virus structural proteins by proteolytic cleavage of a precursor polypeptide.

Authors:  V M Vogt; R Eisenman; H Diggelmann
Journal:  J Mol Biol       Date:  1975-08-15       Impact factor: 5.469

2.  Virus-specific precursor polypeptides in cells infected with Rauscher leukemia virus: synthesis, identification, and processing.

Authors:  D Van Zaane; J A Dekker-Michielsen; H P Bloemers
Journal:  Virology       Date:  1976-11       Impact factor: 3.616

3.  Complete nucleotide sequence of the AIDS virus, HTLV-III.

Authors:  L Ratner; W Haseltine; R Patarca; K J Livak; B Starcich; S F Josephs; E R Doran; J A Rafalski; E A Whitehorn; K Baumeister
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

4.  Comparison of immature (rapid harvest) and mature Rous sarcoma virus particles.

Authors:  K S Cheung; R E Smith; M P Stone; W K Joklik
Journal:  Virology       Date:  1972-12       Impact factor: 3.616

5.  Maturation of Moloney murine leukemia virus.

Authors:  A H Lu; M M Soong; P K Wong
Journal:  Virology       Date:  1979-02       Impact factor: 3.616

6.  Further characterization of intracellular precursor polyproteins of Rauscher leukemia virus.

Authors:  G A Jamjoom; R B Naso; R B Arlinghaus
Journal:  Virology       Date:  1977-05-01       Impact factor: 3.616

7.  A joint produce of the genes gag and pol of avian sarcoma virus: a possible precursor of reverse transcriptase.

Authors:  H Oppermann; J M Bishop; H E Varmus; L Levintow
Journal:  Cell       Date:  1977-12       Impact factor: 41.582

8.  "gag" polyprotein precursors of Rauscher murine leukemia virus.

Authors:  L J Arcement; W L Karshin; R B Naso; R B Arlinghaus
Journal:  Virology       Date:  1977-09       Impact factor: 3.616

9.  Effect of p15-associated protease from an avian RNA tumor virus on avian virus-specific polyprotein precursors.

Authors:  K Moelling; A Scott; K E Dittmar; M Owada
Journal:  J Virol       Date:  1980-02       Impact factor: 5.103

10.  The oncornavirus maturation process: quantitative correlation between morphological changes and conversion of genomic virion RNA.

Authors:  J Korb; M Trávnícek; J Ríman
Journal:  Intervirology       Date:  1976       Impact factor: 1.763

View more
  105 in total

Review 1.  Ubiquitin in retrovirus assembly: actor or bystander?

Authors:  V M Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

2.  Ubiquitin is part of the retrovirus budding machinery.

Authors:  A Patnaik; V Chau; J W Wills
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

3.  HIV-1 protease cleaves eukaryotic initiation factor 4G and inhibits cap-dependent translation.

Authors:  I Ventoso; R Blanco; C Perales; L Carrasco
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

4.  Human immunodeficiency virus type 1 (HIV-1) protein Vif inhibits the activity of HIV-1 protease in bacteria and in vitro.

Authors:  M Kotler; M Simm; Y S Zhao; P Sova; W Chao; S F Ohnona; R Roller; C Krachmarov; M J Potash; D J Volsky
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

5.  The late stage of human immunodeficiency virus type 1 assembly is an energy-dependent process.

Authors:  M Tritel; M D Resh
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

6.  Roles of matrix, p2, and N-terminal myristoylation in human immunodeficiency virus type 1 Gag assembly.

Authors:  Y Morikawa; D J Hockley; M V Nermut; I M Jones
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

7.  Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease.

Authors:  Steve C Pettit; Gavin J Henderson; Celia A Schiffer; Ronald Swanstrom
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

8.  p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.

Authors:  M Huang; J M Orenstein; M A Martin; E O Freed
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Distinct nucleic acid interaction properties of HIV-1 nucleocapsid protein precursor NCp15 explain reduced viral infectivity.

Authors:  Wei Wang; Nada Naiyer; Mithun Mitra; Jialin Li; Mark C Williams; Ioulia Rouzina; Robert J Gorelick; Zhengrong Wu; Karin Musier-Forsyth
Journal:  Nucleic Acids Res       Date:  2014-05-09       Impact factor: 16.971

10.  Mutations in human immunodeficiency virus type 1 nucleocapsid protein zinc fingers cause premature reverse transcription.

Authors:  James A Thomas; William J Bosche; Teresa L Shatzer; Donald G Johnson; Robert J Gorelick
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.